Brenus Pharma

Bring the immune system one step ahead of cancer

Lyon, France · Founded 2020 · $37.6M raised

Headquarters
Lyon
Founded
2020
Business Model
B2B
Total Funding
$37.6M
Last Round
$12.6M Extension RoundJul 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Brenus Pharma is a clinical-stage biotech based in Lyon, France, founded in 2020, developing next-generation in vivo immunotherapies to prevent cancer recurrence in solid tumors, the leading driver of the 10 million cancer deaths worldwide each year. Using an off-the-shelf tumor bank platform, the company creates hapten-tagged 'ghost cells' that mimic tumor heterogeneity to re-educate the immune system against evolving cancer cells. It has raised roughly €30 million since 2020 and is advancing two clinical candidates toward IND filing by 2027, including STC-1010 for metastatic colorectal cancer.

Summary

Brenus Pharma is a Biotech company based in Lyon, France, founded in 2020. It has raised $37.6M in total across 2 rounds, most recently a $12.6M Extension Round in Jul 2026. Investors include UI Investissement, Credit Agricole and Noshaq.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A ExtensionJul 2026
$12.6M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Brenus Pharma on Indexed.vc
<a href="https://indexed.vc/companies/brenus-pharma"><img src="https://indexed.vc/api/badge/company/brenus-pharma" alt="Brenus Pharma on Indexed.vc" width="260" height="76" /></a>